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Summary. Two actions of clinically used antiepileptic drugs have been stud- 
ied using mouse neurons in primary dissociated cell culture. The antiepileptic 
drugs phenytoin, carbamazepine and valproic acid were demonstrated to limit 
sustained high frequency repetitive firing of action potentials at free serum 
concentratons that are achieved in patients being treated for epilepsy. Fur- 
thermore, an active metabolite of carbamazepine also limited sustained high 
frequency repetitive firing while inactive metabolites of phenytoin and car- 
bamazepine did not limit sustained high frequency repetitive firing. Phenobar- 
bital and clinically used benzodiazepines limited sustained high frequency re- 
petitive firing of action potentials, but only at concentrations achieved during 
the treatment of generalized tonic-clonic status epilepticus. Ethosuximide did 
not limit sustained high frequency repetitive firing even at concentrations four 
times those achieved in the serum of patients treated for generalized absence 
seizures. Phenobarbital and clinically used benzodiazepines enhanced postsyn- 
aptic GABA responses at concentrations achieved free in the serum during 
treatment of generalized tonic-clonic or generalized absence seizures. However, 
phenytoin, carbamazepine, valproic acid and ethosuximide did not modify post- 
synaptic GABA responses at therapeutic free serum concentrations. These re- 
sults suggest that the ability of antiepileptic drugs to block generalized tonic- 
clonic seizures and generalized tonic-clonic status epilepticus may be related to 
their ability to block high frequency repetitive firing of neurons. The mechanism 
underlying blockade of myoclonic seizures may be related to the ability of 
antiepileptic drugs to enhance GABAergic synaptic transmission. The mech- 
anism underlying management of generalized absence seizures remains unclear. 
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Introduction 
Antiepileptic drugs have been demonstrated to be of use in the management 
of patients with various types of epilepsy. Patients can be successfully managed 
for generalized tonic-clonic, generalized absence and myoclonic seizures with 
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a number of primary antiepileptic drugs (Woodbury et al., 1982). The primary 
drugs that are currently in use are phenytoin, carbamazepine, primidone, pheno- 
barbital, clonazepam, valproic acid and ethosuximide. Selection of antiepileptic 
drug is determined by the type of seizure disorder that has been diagnosed. For 
example, in patients with primary generalized tonic-clonic seizures, the drug of 
choice is phenytoin or carbamazepine, although valproic acid has been shown 
to be as effective as the two first-line drugs. In contrast, myoclonic seizures are 
treated primarily by valproic acid or benzodiazepines such as clonazepam. In 
the therapy of generalized absence seizures, ethosuximide is the drug of choice, 
but for generalized absence seizures in combination with other seizure types, 
valproic acid is more effective. Benzodiazepines such as clonazepam have been 
shown also to be effective, but their use is often limited by the development of 
tolerance. 
The major antiepileptic drugs also have a different spectrum of action against 
seizures induced in experimental animals (Krall et al., 1978). Two primary 
experimental seizures have been used to assess the effectivenes of these drugs. 
Maximal electroshock seizures can be blocked at nontoxic doses by phenytoin, 
carbamazepine, primidone, phenobarbital and vatproic acid. Clonazepam will 
block maximal electroshock seizures, but only at toxic concentrations. Etho- 
suximide is relatively ineffective against this experimental seizure type. Sub- 
cutaneous pentylenetetrazol produces primarily clonic seizures in experimental 
animals. These seizures can be blocked by phenobarbital, clonazepam, valproic 
acid and ethosuximide. Phenytoin, carbamazepine and primidone are relatively 
ineffective against this seizure type. 
The basic mechanisms underlying the selectivity of antiepileptic drugs are 
uncertain. Data obtained from the clinical use of antiepileptic drugs and from 
antiepileptic drug selectivity in experiment animals suggest that antiepileptic 
drugs may have multiple mechanisms of action. Recently, two actions of an- 
tiepileptic drugs have been shown to be potential antiepileptic mechanisms; 
reduction of sustained high frequency repetitive firing and enhancement of 
GABAergic synaptic transmission (Macdonald, 1983; Macdonald and McLean, 
1986). In this article, I will review some data supporting the hypotheses that 
these two actions are antiepileptic. 
Materials and methods 
Intracellular recordings have been made from spinal cord, cortical and hippocampal neurons 
grown in primary dissociated cell culture. Neurons were taken from the relevant location 
in the spinal cord or central nervous system, mechanically disrupted, dissociated and plated 
as a single cell suspension on collagen-coated 35 mm plastic dishes. While culture conditions 
varied somewhat depending upon the region of the nervous system that was placed in 
culture, cultures were grown for 4-12 weeks prior to intracellular recording. For specific 
details of the culture technique, see McLean and Macdonald, 1986. 
Intracellular recordings were made from neurons bathed in a physiological salt solution 
at 37 ~ Cells were accepted only if their resting membrane potentials exceeded - 50 mV. 
From resting membrane potential a series of depolarizing current pulses of variable du- 
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rations were applied and the evoked action potentials were photographed. Under control 
conditions, spinal cord and cortical neurons respond to progessively increasing depolarizing 
pulses with an increasing number and frequency of action potentials. Within 5 mV of 
obtaining threshold for the initial action potentials, a steady rate of action potential firing 
can be evoked. With increasing depolarizing pulses above threshold, the rate of firing 
increases. To asses the effect of antiepileptic drugs, recordings were obtained from a series 
of spinal cord, cortical or hippocampal neurons. Cultures were discarded if sustained 
repetitive firing could not be elicited in the control neurons. An antiepiteptic drug at an 
appropriate concentration was added to the bath and mixed. Different neurons were then 
recorded from and the results on repetitive firing were compared to those obtained from 
neurons in control medium. 
To study the effect of antiepileptic drugs on GABA responses, iontophoretic pipettes 
filled with GABA (0.5 M, pH 3.5) positioned within 2 g of the surface of a neuron which 
had been impaled. Positive current pulses (100 to 400 msec) were applied to the iontophoretic 
pipettes at a rate of 0.2 Hz. Intracellular recordings were made with potassium chloride 
(3 M) filled micropipettes, and membrane potential was held more negative than - 7 0  inV. 
Under these conditions, GABA responses were depolarizing since the chloride equilibrium 
potential is about - 3 0  inV. After a stable GABA response which was less than 10 mV was 
recorded, a blunt-tipped pipette containing an antiepileptic drug which was dissolved in 
recording medium was brought up adjacent to the iontophoretic pipette and either pressure 
applied or allowed to bathe the area by local diffusion. After a stable enhancement or 
reduction of GABA responses was recorded, the antiepileptic drug-containing pipette was 
withdrawn and control responses were recovered. All data were discarded if control and 
recovery GABA responses were not within 5% of each other. 
Selection of antiepileptic drug concentration was guided by information obtained in 
human studies. Antiepileptic drugs vary in their protein binding in serum. Benzodiazepines 
such as diazepam are bound to a high degree (97-98%). In contrast ethosuximide is not 
protein bound. It is the unbound anticonvulsant drug which equilibrates with cerebrospinal 
fluid and therefore extracellular space in the nervous system. Therefore, an action of an 
antiepileptic drug should occur at a concentration which is found in CSF or which is found 
free in plasma. Accordingly actions of antiepileptic drugs were considered potentially rel- 
evant for clinical use if they occurred at concentrations of antiepileptic drugs in free serum 
or CSF during therapy. 
Results 
Reduction of sustained high frequency repetitive firing by antiepileptic drugs 
Intracel lular  recordings were obta ined f rom spinal cord,  cortical and  hippo- 
campal  neurons  in cell culture. W h e n  a 400-500 msec depolarizing cur ren t  was 
applied th rough  the recording pipette, a volley of  act ion potentials was elicited 
(Fig. 1, CONT) .  Increasing the magni tude  of  the current  injection p roduced  
increased m e m b r a n e  depolar izat ion associated with volleys o f  act ion potentials 
at higher frequencies.  Over a wide range o f  depolarizing pulses, act ion potent ial  
firing was sustained t h roughou t  the pulse. The frequencies of  act ion potential  
firing approached  500 Hz. Therefore ,  in cont ro l  neurons,  depolarizing cur ren t  
injections p roduced  sustained high f requency repetitive firing. W h e n  sodium 
valproate  (McLean  and  Macdona ld ,  1986a), phenyto in  (McLean  and Mac-  
donald,  1983b) and carbamazepine  (McLean  and Macdona ld ,  1983 a; 1986b) 
were ba th  applied, a different  pa t te rn  of  repetitive firing was observed (Fig. 1). 
In  a dose-dependent  fashion, all three antiepileptic drugs limited the ability of  
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individual neurons to sustain high frequency repetitive firing. At increasing 
antiepileptic drug concentration, an increasing percentage of neurons failed to 
respond to depolarizing current pulses with sustained firing. Instead, these 
neurons fired a series of action potentials at moderately high frequency with 
rapidly declining amplitudes and maximal rates of rise. During the depolarizing 
pulse, action potentials failed. This failure to sustain high frequency repetitive 
firing was seen over a large range of depolarizing current pulses. While all three 
antiepileptic drugs limited sustained high frequency repetitive firing, they did 
not affect the amplitude, duration or maximal rate of rise of the first action 
potential in each train. Sodium valproate limited sustained repetitive firing at 
concentrations above 0.6 gM and approximately 80% of neurons showed lim- 
itation at 12 gM. Phenytoin limited sustained high frequency repetitive firing 
in neurons at concentrations above 0.2 [aM and limited sustained repetitive firing 
in 80% of neurons at 8 gM. Carbamazepine limited sustained high frequency 
repetitive firing in neurons above 0.84 gM and produced an 80% reduction in 
the percentage of neurons firing sustained repetitive firing at 4.2 gM. Concen- 
trations over which sodium valproate, phenytoin and carbamazepine had their 
action on sustained repetitive firing were equal to the free serum concentrations 
achieved in patients treated for generalized tonic-clonic seizures with t h e s e  
antiepileptic drugs. 
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Fig. 1. Valproic acid (NaVP), phenytoin (PT), and carbamazepine (CBZ) limited sustained 
high frequency repetitive firing. Intracellular recordings were made from spinal cord neurons 
in cell culture and increasing depolarizing current pulses were applied. Magnitude of the 
current pulses is shown below each of the traces and the membrane potentials from which 
the depolarizing pulses were obtained are shown below each column. In control (CONT) 
medium sustained high frequency repetitive firing was obtained throughout all ranges of 
depolarization. In the presence of sodium valproate (12 gM), phenytoin (8 gM), and car- 
bamazepine (8.5 gM) limitation of sustained repetitive firing was seen at each of the mem- 
brane depolarization (McLean and Macdonald, unpublished) 
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Antiepileptic drugs are metabolized in the liver and the resultant metabolites 
attained levels in the cerebrospinal fluid and in the nervous system. We have 
studied some of these metabolites to determine whether or not they had similar 
effects on repetitive firing. Phenytoin is metabolized primarily to the parahy- 
droxylated derivative 5-p-hydroxyphenyl-5-phenyl hydantoin (HPPH). HPPH 
is not antiepileptic when administered to experimental animals but does not 
cross the blood brain barrier in large quantities. Therefore it is not certain 
whether it has an antiepileptic action. However, HPPH had no effect on sus- 
tained high frequency repetitive firing at concentrations up to 40 gM (McLean 
and Macdonald, 1983 b). Carbamazepine is metabolized to 2 metabolites, car- 
bamazepine epoxide and carbamazepine dihydroxide. Carbamazepine epoxide 
has been shown to have antiepileptic action in experimental animals while 
carbamazepine dihydroxide has been shown to ineffective against experimental 
seizures. Carbamazepine epoxide limited sustained high frequency repetitive 
firing at concentrations comparable to carbamazepine while the dihydroxide 
derivative of carbamazepine was not effective at concentrations 10 times those 
effective for carbamazepine (McLean and Macdonald, 1983 a; 1986 b). Valproic 
acid has many metabolites but one major metabolite is the 2-en-valproic acid 
(2-en-VPA) (Nau and L6scher, i982). 2-en-VPA had no effect on sustained 
high frequency repetitive firing (McLean and Macdonald, 1986a) at concen- 
trations achieved in experimental animals (Nau and L6scher, 1982). These 
results suggest that one metabolite of carbamazepine may also contribute to 
its antiepileptic action but that the metabolites of phenytoin and valproic acid 
studied may be ineffective. 
In contrast to the actions of sodium valproate, phenytoin and carba- 
mazepine, the antiepileptic drugs primidone, phenobarbital, clonazepam and 
ethosuximide did not limit sustained high frequency repetitive firing a thera- 
peutic free serum concentrations (Skerritt et al., 1984a, b; Macdonald and 
McLean, 1986; McLean and Macdonald, 1986a). Primidone, phenobarbital 
and clonazepam limited sustained high frequency repetitive firing but only at 
concentrations that exceeded therapeutic free serum concentrations. Concen- 
trations required for primidone and phenobarbital were over 200 p,M and for 
clonazepam were over 50 nM. These concentrations are achieved in patients 
being treated for generalized tonic-clonic status epilepticus but are generally 
not achieved in ambulatory patients. These are usually sedating concentrations 
of antiepileptic drugs. Ethosuximide did not limit repetitive firing even at con- 
centrations which were supratherapeutic. 
The absence of effect of the antiepileptic drugs on resting membrane prop- 
erties suggested that the antiepileptic drugs were acting directly on sodium 
channels to limit repetitive firing. In spinal cord and cortical neurons, action 
potentials are primarily sodium-dependent. The maximal rate of rise of action 
potentials has been used as an indirect measure of the inward sodium current. 
In spinal cord neurons, we have demonstrated that the amplitude of action 
potentials is proportional to the logarithm of the extracellutar sodium concen- 
trations, thus demonstrating that these action potentials are sodium-dependent. 
Therefore, to study the effect of antiepileptic drugs on sodium channels, we 
used the maximal rate of rise of the action potential as an indirect assay of 
sodium current. 
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Fig. 2. Limitation of sustained repetitive firing by sodium valproate, phenytoin and car- 
bamazepine was use-dependent. The use-dependent effect of the antiepileptic drugs is shown 
for NaVP. In control medium, sustained repetitive firing was obtained (control). The 
maximum rate of rise of individual action potentials (s is plotted as a function of the 
action potential number within a train (see insert). In control medium, the initial action 
potential had the largest s Subsequent action potentials had slightly smaller s215 values 
until a relative steady state was achieved, in NaVP (12 gM), the Vma~ of the initial action 
potential was identical to that seen in control medium. However, there was a rapid reduction 
in s215 as a function of the number of action potential in the train. In NaVP, only 11 
action potentials were evoked and repetitive firing was therefore limited. This reduction in 
the number of action potentials was associated with this use-dependent reduction of the 
~rma x of the action potentials (from McLean and Macdonald, 1986) 
The effect of sodium valproate, phenytoin and carbamazepine varied de- 
pending upon the membrane potential of the neuron, i.e., the effect of these 
antiepileptic drugs on repetitive firing was voltage-dependent. The ability of 
the antiepileptic drugs to limit repetitive firing was apparent only following 
membrane depolarization. When neurons were depolarized, a clear reduction 
in sustained repetitive firing was produced by the antiepileptic drugs. However, 
following membrane hyperpolarization, neurons could achieve sustained re- 
petitive firing despite the presence of the antiepileptic drug. 
The effect of the antiepileptic drugs on sustained repetitive firing was also 
use- or frequency-dependent (Fig. 2). The antiepileptic drugs did not modify 
the rate of rise, amplitude or duration of single action potentials evoked over 
a wide range of voltages. However, with repetitive stimulation or with sustained 
depolarization producing repetitive firing, there was a progressive reduction in 
the amplitude and maximal rate of rise of successive action potentials. With 
repetitive stimulation or sustained depolarization, failure of action potential 
firing occurred. Thus, to produce the reduction in action potentials duration, 
rate of rise and amplitude, repeated action potentials had to be evoked. 
Enhancement of GABA responses by antiepileptic drugs 
Phenobarbital  (Macdonald and Barker, 1979a; Schulz and Macdonald,  1981) 
and the benzodiazepines diazepam, nitrazepam and clonazepam (Choi et al., 
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Fig. 3. Barbiturates and benzodiazepines enhanced responses of spinal cord neurons to 
iontophoretically-applied GABA. Each row shows sequential chart recordings of responses 
produced in single spinal cord neurons by iontophoretic application of GABA before (PRE), 
during (DR UG), and after (POST) pressure ejection of antiepileptics from a pressure ejection 
micropipette position nearby. Membrane potentials were - 70 to - 80 mV and intracellular 
recordings were made using 3 molar KC1 micropipettes. Under these conditions, GABA 
responses were depolarizing, Phenobarbital, clonazepam, and diazepam rapidly and re- 
versibly enhanced the GABA responses (from Macdonald and MacLean, 1985) 
1977; Macdonald and Barker, 1978; Skerritt and Macdonald, 1984) all enhanced 
iontophoretically produced GABA responses (Fig. 3). Enhancement by all three 
drugs was rapid in onset and was reversible. Phenobarbital enhanced GABA 
responses at concentrations above 20 gM with a 20-25% enhancement being 
produced at 100~tM. The benzodiazepines clonazepam and diazepam were 
substantially more potent than phenobarbital, producing enhancements in 
GABA responses at concentrations above 1 nM and producing 80-100% en- 
hancements at 100 nM. Nitrazepam was slightly less potent than clonazepam 
and diazepam. Valproic acid and phenytoin enhanced GABA responses only 
at nontherapeutic concentrations. Carbamazepine, primidone and ethosuximide 
did not modify GABA responses. 
Phenobarbital, but not the benzodiazepines, reduced glutamate responses 
evoked in spinal cord neurons bathed in a high magnesium solution (Macdonald 
and Barker, 1979b). The glutamate responses were most likely produced by 
binding to quisqualate receptors. No attempt to study NMDA or kainate 
responses was made in these experiments. 
Discussion 
We have demonstrated that antiepileptic drugs effective against generalized 
tonic-clonic seizures and generalized tonic-clonic status epilepticus had an action 
on neuronal excitability. Phenytoin, carbamazepine and valproic acid blocked 
sustained high frequency repetitive firing at free serum concentrations that are 
acieved in ambulatory patients being treated for epilepsy. Phenobarbital and 
antiepileptic benzodiazepines limited sustained high frequency repetitive firing 
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at concentrations achieved during the treatment of generalized tonic-clonic 
status epilepticus but not at those achieved in ambulatory patients. Finally, 
ethosuximide did not limit sustained high frequency repetitive firing even at 
concentrations several fold higher than those achieved in patients being treated 
for generalized absence seizures. These results suggest that reduction of sustained 
high frequency repetitive firing by antiepileptic drugs may form, in part, the 
basis for antiepileptic action against generalized tonic-clonic seizures and gen- 
eralized tonic-clonic status epilepticus. The mechanism of the limitation of 
sustained high frequency repetitive firing has not been definitively demonstrated. 
However, since the antiepileptic drugs have no effect on resting membrane 
properties of these neurons and since there is a use-dependent and voltage- 
dependent reduction of the maximal rate of rise of action potentials in the 
trains, it is likely that the antiepileptic drugs are directly affecting sodium 
channels. The effect of the drugs is not to block directly the channels since 
single action potentials evoked at all voltages were unaffected by these anti- 
epileptic drugs. The blockade of sodium channels produced by the antiepileptic 
drugs was use- or frequency-dependent. With repetitive stimulation or during 
repetitive firing of action potentials within trains, the antiepileptic drugs began 
to have their effects on maximal rate of rise only after the firing of several 
action potentials. Furthermore, the reduction in the maximal rate of rise of the 
action potentials increased as the number of action potentials evoked increased. 
Block of repetitive firing by the antiepileptic drugs was also voltage-dependent. 
The blockade could be relieved by membrane hyperpolarization and was ex- 
acerbated following membrane depolarization. A common feature of repetitive 
firing and of membrane depolarization is the increasing presence of inactive 
sodium channels. These data suggest that the antiepileptic drugs are binding 
to the sodium channels when they are in their inactive state. This mechanism 
is similar to the modulated receptor hypothesis that has been used to describe 
the mechanism of action of local anesthetics (Hille, 1977; Hondeghem and 
Katzung, 1977). The action of phenytoin on sodium currents has been studied 
in neuroblastoma cells recently. These studies have confirmed an effect of 
phenytoin on the inactivation process. However, in one study (Willow et al., 
1984), an effect of phenytoin on fast sodium channel inactivation was reported, 
while in a second study on neuroblastoma neurons (Matsuki et al., 1984), an 
effect of slow sodium channel inactivation was reported. A major limitation in 
studying the effect of antiepileptic drugs on sodium currents in vertebrate 
neurons is their morphology. Vertebrate neurons including those in culture have 
multiple large dendrites and axons originating from cell bodies or proximal 
dendrites. Voltage clamp studies are extremely difficult on neurons with such 
morphology, and it has not been possible for us to study sodium currents in 
these vertebrate neurons. Therefore, a definitive characterization of the mech- 
anism of antiepileptic drug action on sodium channels may await the application 
of patch clamp techniques to single sodium channels. 
Some antiepileptics drugs also enhance GABA-mediated inhibition. While 
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both barbiturates and benzodiazepines enhance GABA responses, their mech- 
anism of action is likely to be different. Benzodiazepines bind to a specific 
benzodiazepine receptor (M6hler, Okada, 1977; Squires and Braestrup, 1977), 
while barbiturates appear to enhance GABA responses by binding to the TBPS, 
or picrotoxin, binding site (Ticku et al., 1978; Squires et al., 1983). Valproic 
acid did not enhance GABA responses at therapeutic concentrations but has 
been shown to increase brain GABA levels. It has been suggested that valproic 
acid increases GABA responses by increasing presynaptic release of GABA. 
However, this effect of  valproic acid has not been demonstrated directly (Godin 
et al., 1969; see Chapman et al., 1982, for review). Therefore, it remains uncertain 
whether valproic acid enhances GABAergic synaptic transmission. 
The correlation of enhancement of GABAergic synaptic transmission with 
antiepileptic drug action is less obvious. In experimental animals, the ability of 
the anticonvulsant drugs to enhance GABA responses correlates well with their 
ability to suppress pentylenetetrazol-induced clonic seizures. The pentylene- 
tetrazol seizure model is predictive, in general, for actions of antiepileptic drugs 
on generalized absence seizures. However, while diazepam is a good anti-absence 
seizure drug, phenobarbital is not. Furthermore, valproic acid and ethosuximide 
are excellent antiabsence seizure drugs and neither had an action on GABA 
responses. While it is possible that valproic acid increases GABAergic synaptic 
transmission by increasing the presynaptic release of transmitter, no direct effect 
of ethosuximide on a GABA system has been demonstrated (Barnes and Dichter, 
1984; McLean and Macdonald, 1986 a). Thus, the effect of anti-absence seizure 
drugs on GABAergic inhibition is poorly correlated. However, the correlation 
of GABA enhancement with treatment of myoclonic seizures is somewhat better. 
Phenobarbital, benzodiazepines and valproic acid are all useful drugs in the 
treatment of myoclonic seizures while ethosuximide is not effective. Thus, if 
valproic acid does increase the release of GABA, all three antimyoclonic seizure 
drugs may produce their action through an enhancement of GABAergic synaptic 
transmission. The question remains, what is the antiabsence seizure mechanism 
of these antiepileptic drugs. It is possible that the enhancement of GABAergic 
synaptic transmission is one mechanism whereby antiepileptic drugs can block 
generalized absence seizures. This, however, cannot be the sole mechanism for 
antiabsence seizure action. It is almost certain that ethosuximide has a different 
action than those of the benzodiazepines and valproic acid. This mechanism, 
however, remains to be elucidated. 
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